The required mesylate 8a was prepared as reported previously.4a
N-Alkylation of the 2-formylpyrrole (7) with the mesylate 8a and
5-bromopentene (8b) afforded 5a and 5b respectively, in good
yields (Scheme 2). With these substrates in hand, we were in a
position to realize the radical process. To our delight, exposure of
a refluxing solution of the corresponding pyrrole 5 and xanthate
97 in 1,2-dichlorethane (DCE) under typical radical-forming
conditions, i.e., portionwise (7 h) addition of 1.3 eq of dilauroyl
peroxide (DLP) to a refluxing solution, led to the formation of
pyrrole 4a and 4b as the major products in 71% and 69% yield,
respectively. Interestingly, addition of a tertiary (reaction of 5a) or
a secondary (reaction of 5b) radical onto the pyrrole nucleus did
not significantly affect the outcome of the reaction. Noteworthy,
xanthate derivatives 10a–b that would come from the normal
addition/xanthate-transfer mechanism, frequently observed in
related processes, was not detected in the reaction media.7 Thus,
this two-step synthetic sequence gave access to 4a (Scheme 2).
It is worth mentioning that the methyl-ester congener has been
transformed into the ( )-rhazinal 1 previously.4a
Scheme 3 Synthesis of ( )-desethylrhazinal.
Acknowledgements
Financial support from the CONACYT (No. 82643) is gratefully
acknowledged. We also thank R. Patin˜o, A. Pen˜a, E. Huerta E.
Garc´ıa-Rios, L. Velasco, and J. Pe´rez for technical support.
References
1 T.-S. Kam, Y.-M. Tee and G. Subramanian, Nat. Prod. Lett., 1998, 12,
307.
2 (a) H. H. A. Linde, Helv. Chim. Acta, 1965, 48, 1822; (b) A. Banerji, P.
L. Majumder and A. Chatterjee, Phytochemistry, 1970, 9, 1491; (c) T. S.
Kam and K. H. Lim, The alkaloids, 2008, 66, 1–110.
3 (a) B. David, T. Se´venet, O. Thoison, K. Awang, M. Pa¨ıs, M. Wright and
D. Gue´nard, Bioorg. Med. Chem. Lett., 1997, 7, 2155; (b) O. Baudoin, F.
Claveau, S. Thoret, A. Herrbach, D. Gue´nard and F. Gue´ritte, Bioorg.
Med. Chem., 2002, 10, 3395; (c) O. Baudoin, D. Gue´nard and F. Gue´ritte,
Mini-Rev. Org. Chem., 2004, 1, 333.
Scheme 2 Preparation of indolizidines 4a and 4b via a tandem addi-
tion/cyclization process.
4 (a) M. G. Banwell, A. J. Edwards, K. A. Jolliffe, J. A. Smith, E. Hamel
and P. Verdier-Pinard, Org. Biomol. Chem., 2003, 1, 296–305; (b) M.
G. Banwell, D. A. S. Beck and A. C. Willis, ARKIVOC, 2006, iii, 163–
174.
5 D. Trauner and A. L. Bowie, J. Org. Chem., 2009, 74, 1581–
1586.
To complete the synthesis of 3, pyrrole 4b was regioselectively
iodinated to afford 11. Then, the Suzuki-Miyaura cross coupling
of 11 with the N-Boc-aniline boronic ester 12 occurred using
Buchwald SPhos ligand and yielded the 3-aryl pyrrole 13. Finally,
ester saponification followed by the removal of the N-Boc
protecting group afforded the corresponding amino acid which,
without further purification, was submitted to the construction of
the nine-member lactam to deliver the ( )-desethylrhazinal 3 in
29% yield over three steps (Scheme 3).
In conclusion, we have achieved the synthesis of ( ) desethyl-
rhazinal using a tandem radical addition-cyclization process, in
seven steps and approximately 12% overall yield, and a practical
short protocol to construct an advanced intermediate in the
synthesis of ( )-rhazinal 1, both from 2-formylpyrrole. We are
currently studying the feasibility of this synthetic strategy for the
synthesis of ( )-rhazinal, ( )-rhazinilam and other members of the
Kopsia alkaloid family.
6 (a) Y. M. Osornio and L. D. Miranda, Rev. Soc. Qu´ım. Me´x., 2004,
48, 288–292; (b) L. D. Miranda, R. Cruz-Almanza and M. Pavon,
ARKIVOC, 2002, (xii), 15–22; (c) L. D. Miranda, R. Cruz-Almanza,
M. Pavo´n, Y. Romero and J. M. Muchowski, Tetrahedron Lett., 2000,
41, 10181; (d) L. D. Miranda, R. Cruz-Almanza, A. Alvarez-Garc´ıa and
J. M. Muchowski, Tetrahedron Lett., 2000, 41, 3035; (e) L. D. Miranda,
R. Cruz-Almanza, M. Pavo´n, E. Alva and J. M. Muchowski, Tetrahedron
Lett., 1999, 40, 7153.
7 (a) A. Biechy and S. Z. Zard, Org. Lett., 2009, 11, 2800–2803; (b) F.
Lebraux, B. Quiclet-Sire and S. Z. Zard, Org. Lett., 2009, 11, 2844–
2847; (c) M. El Qacemi, L. Ricard and S. Z. Zard, Chem. Commun.,
2006, 4422–4424; (d) E. Bacque´, M. El Qacemi and S. Z. Zard, Org. Lett.,
2004, 6, 3671–3674; (e) F. Gagosz. and S. Z. Zard, Org. Lett., 2002, 4,
4345–4348; (f) Y. M. Osornio and L. D. Miranda, Rev. Soc. Qu´ım. Me´x.,
2004, 48, 288–292; (g) E. W. Tate and S. Z. Zard, Tetrahedron Lett., 2002,
43, 4683–4686; See also 6a.
362 | Org. Biomol. Chem., 2011, 9, 361–362
This journal is
The Royal Society of Chemistry 2011
©